Cardiva Announces FDA Approval of the VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure Following Electrophysiology Procedures

SCCR, in collaboration with the Stanford Quantitative Sciences Unit (QSU), successfully completed enrollment for AMBULATE study, sponsored by Cardiva Medical in June 2018. The study was planned and executed under the leadership of Mintu Turakhia as principal investigator and Kenneth Mahaffey as operations principle investigator. VASCADE MVP, the closure system used in the AMBULATE trial, received FDA approval on November 28th!